IMAC (IMAC) Competitors

CareCloud (NASDAQ:CCLD) and IMAC (NASDAQ:IMAC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

Is CCLD or IMAC more profitable?

CareCloud has a net margin of -35.25% compared to IMAC's net margin of -75.40%. IMAC's return on equity of -52.17% beat CareCloud's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	-35.25%	-87.98%	-50.79%
IMAC	-75.40%	-52.17%	-34.51%

Which has higher valuation & earnings, CCLD or IMAC?

IMAC has lower revenue, but higher earnings than CareCloud.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$117.06M	0.49	-$48.67M	-$3.20	-1.11
IMAC	$15.22M	1.14	-$10.54M	N/A	N/A

Does the MarketBeat Community believe in CCLD or IMAC?

IMAC received 63 more outperform votes than CareCloud when rated by MarketBeat users. However, 61.54% of users gave CareCloud an outperform vote while only 60.17% of users gave IMAC an outperform vote.

Company	Underperform	Outperform
CareCloud	Outperform Votes 8 61.54%	Underperform Votes 5 38.46%
IMAC	Outperform Votes 71 60.17%	Underperform Votes 47 39.83%

Which has more risk and volatility, CCLD or IMAC?

CareCloud has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500. Comparatively, IMAC has a beta of -0.88, suggesting that its stock price is 188% less volatile than the S&P 500.

Does the media favor CCLD or IMAC?

In the previous week, IMAC had 5 more articles in the media than CareCloud. MarketBeat recorded 5 mentions for IMAC and 0 mentions for CareCloud. IMAC's average media sentiment score of 0.23 beat CareCloud's score of 0.00 indicating that IMAC is being referred to more favorably in the news media.

Company	Overall Sentiment
CareCloud	Neutral
IMAC	Neutral

Do institutionals and insiders hold more shares of CCLD or IMAC?

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 24.3% of IMAC shares are owned by institutional investors. 38.4% of CareCloud shares are owned by insiders. Comparatively, 10.0% of IMAC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Do analysts rate CCLD or IMAC?

CareCloud presently has a consensus price target of $3.67, indicating a potential upside of 3.17%. Given CareCloud's stronger consensus rating and higher possible upside, equities research analysts plainly believe CareCloud is more favorable than IMAC.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
IMAC	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

CareCloud and IMAC tied by winning 8 of the 16 factors compared between the two stocks.